Lubner David Charles
SEC CIK 1572000 · EDGAR
BoughtSold
Most active insiders at BRVE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Forbion Growth Opportunities Fund III Cooperatief U.A. | 10% | $64.80M | — |
| 2 | Chimovits Erez | Dir, 10% | $34.92M | — |
| 3 | ORBIMED ADVISORS LLC | Dir, 10% | $34.92M | — |
| 4 | AH Bio Fund IV, L.P. | 10% | $19.80M | — |
| 5 | Murdoch Travis | CEO, Pres, Dir | $1.50M | — |
| 6 | Viehbacher Christopher | Dir | $1.50M | — |
| 7 | Lubner David Charles | Dir | $1000.0K | — |
| 8 | Rickey James Paul | CFO | $500.0K | — |
| 9 | Malek David I | Dir | $75.0K | — |
| 10 | Anderson Michele A. | Chief Development Off | $20.0K | — |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-07 16:30 | 2026-08-07 | BRVE | Braveheart Bio, Inc. | Lubner David Charles | Dir | P - Purchase | $18.00 | +55.6K | 55.6K | New | +$1000.0K |
| 2026-04-28 16:56 | 2026-04-24 | DYN | Dyne Therapeutics, Inc. | Lubner David Charles | Dir | G - Gift | $0.00 | -53.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations